Top U.S. cholesterol-lowering drugs - market share by prescriptions 2013
This statistic displays the market share of the top HMG-CoA reductase inhibitors based on total U.S. prescriptions in 2013. In that year, Crestor was among the leading HMG-CoA reductase inhibitors with a market share of 11.1 percent in the United States based on prescriptions. HMG-CoA reductase inhibitors or statins help lower cholesterol levels and is central in cholesterol production within the liver. It is used to prevent heart disease and decrease mortality within those with pre-existing cardiovascular disease.
